NO20074880L - Proteaseinhibitor forloper syntese - Google Patents

Proteaseinhibitor forloper syntese

Info

Publication number
NO20074880L
NO20074880L NO20074880A NO20074880A NO20074880L NO 20074880 L NO20074880 L NO 20074880L NO 20074880 A NO20074880 A NO 20074880A NO 20074880 A NO20074880 A NO 20074880A NO 20074880 L NO20074880 L NO 20074880L
Authority
NO
Norway
Prior art keywords
synthesis
protease inhibitor
proceeds
inhibitor proceeds
processes
Prior art date
Application number
NO20074880A
Other languages
English (en)
Norwegian (no)
Inventor
Bruno Linclau
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20074880L publication Critical patent/NO20074880L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20074880A 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese NO20074880L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05101462 2005-02-25
US68369905P 2005-05-23 2005-05-23
PCT/EP2006/060246 WO2006089942A1 (en) 2005-02-25 2006-02-24 Protease inhibitor precursor synthesis

Publications (1)

Publication Number Publication Date
NO20074880L true NO20074880L (no) 2007-09-25

Family

ID=36646227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074880A NO20074880L (no) 2005-02-25 2007-09-25 Proteaseinhibitor forloper syntese

Country Status (19)

Country Link
US (2) US8067463B2 (zh)
EP (1) EP1856125B1 (zh)
JP (1) JP5260965B2 (zh)
KR (1) KR101333627B1 (zh)
CN (1) CN101128469B (zh)
AT (1) ATE440848T1 (zh)
AU (1) AU2006217922B2 (zh)
BR (1) BRPI0607827B8 (zh)
CA (1) CA2595295C (zh)
DE (1) DE602006008751D1 (zh)
DK (1) DK1856125T3 (zh)
ES (1) ES2331257T3 (zh)
IL (1) IL184519A (zh)
MX (1) MX2007010378A (zh)
NO (1) NO20074880L (zh)
PL (1) PL1856125T3 (zh)
PT (1) PT1856125E (zh)
RU (1) RU2421459C2 (zh)
WO (1) WO2006089942A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5288153B2 (ja) * 2007-03-30 2013-09-11 日油株式会社 糖アルコール誘導体およびアルケニル基含有糖アルコール誘導体の製造方法
WO2012075122A2 (en) * 2010-11-30 2012-06-07 Purdue Research Foundation Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1088098T4 (en) 1998-06-23 2015-09-14 Us Of America Represented By The Secretary Dept Of Health And Human Services Fitnessassay and methods for reducing HIV resistance to therapy
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
EP1089328A1 (en) * 1999-09-29 2001-04-04 Infineon Technologies AG Method for manufacturing of a semiconductor device
EP1222192B8 (en) 1999-10-06 2008-10-01 Tibotec Pharmaceuticals Ltd. Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamate as retroviral protease inhibitor
CZ304273B6 (cs) 2001-02-14 2014-02-12 Tibotec Pharmaceuticals Ltd. 2-(Substitovaná-amino)benzothiazolsulfonamidová sloučenina, způsob její přípravy a farmaceutická kompozice s jejím obsahem
OA12464A (en) 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
US7622490B2 (en) 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
US7087373B2 (en) 2001-06-05 2006-08-08 Tibotec Pharmaceuticals Ltd. Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins
TWI286476B (en) 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
EA009556B1 (ru) 2001-12-21 2008-02-28 Тиботек Фармасьютикалз Лтд. Гетероциклические замещённые фенилсодержащие сульфонамиды широкого спектра действия в качестве ингибиторов протеазы вич
US7109230B2 (en) 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
AU2003208751A1 (en) 2002-02-22 2003-09-09 Tibotec Bvba Methods for determining the influence of protein binding on antiretroviral activity
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US7462608B2 (en) 2002-04-26 2008-12-09 Gilead Sciences, Inc. Non nucleoside reverse transcriptase inhibitors
US7700645B2 (en) 2002-05-16 2010-04-20 Tibotec Pharmaceuticals Ltd. Pseudopolymorphic forms of a HIV protease inhibitor
MXPA04011466A (es) 2002-05-17 2005-02-14 Tibotec Pharm Ltd Inhibidores de la proteasa de hiv de benzisoxazol sulfonamida sustituida de amplio espectro.
EP1520247B1 (en) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance

Also Published As

Publication number Publication date
KR20080005183A (ko) 2008-01-10
ATE440848T1 (de) 2009-09-15
CA2595295A1 (en) 2006-08-31
AU2006217922A1 (en) 2006-08-31
US8183394B2 (en) 2012-05-22
EP1856125B1 (en) 2009-08-26
JP5260965B2 (ja) 2013-08-14
AU2006217922B2 (en) 2012-04-05
DE602006008751D1 (de) 2009-10-08
MX2007010378A (es) 2007-09-25
PT1856125E (pt) 2009-11-06
US8067463B2 (en) 2011-11-29
WO2006089942A8 (en) 2007-12-13
WO2006089942A1 (en) 2006-08-31
US20120041215A1 (en) 2012-02-16
CN101128469A (zh) 2008-02-20
PL1856125T3 (pl) 2010-01-29
RU2007135345A (ru) 2009-03-27
IL184519A0 (en) 2007-10-31
US20090054668A1 (en) 2009-02-26
RU2421459C2 (ru) 2011-06-20
BRPI0607827A2 (pt) 2009-10-06
EP1856125A1 (en) 2007-11-21
KR101333627B1 (ko) 2013-11-27
BRPI0607827B8 (pt) 2021-05-25
CN101128469B (zh) 2012-11-14
IL184519A (en) 2012-01-31
JP2008531522A (ja) 2008-08-14
DK1856125T3 (da) 2009-12-07
ES2331257T3 (es) 2009-12-28
BRPI0607827B1 (pt) 2019-11-05
CA2595295C (en) 2014-07-08

Similar Documents

Publication Publication Date Title
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
ATE530554T1 (de) Serinprotease-hemmer
EA200500201A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
DE602007012559D1 (de) H die schleimhaut
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
ATE453670T1 (de) Acrylierte hyaluronsäure
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
ATE429417T1 (de) Hiv-protease-inhibitoren
DK1480491T3 (da) Tynd højttaler samt fremgangsmåde til fremstilling deraf
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
SG158860A1 (en) Processes for the preparation of aminoethoxybenzyl alcohols
NO20080661L (no) Nye cystein-protease-inhibitorer og deres terapeutiske anvendelser
NO20074880L (no) Proteaseinhibitor forloper syntese
BRPI0607390A2 (pt) Processo para recuperar cci-779 de licores mâe
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
ITMI20060488A1 (it) Procedimento per la preparazione di 3,4-bis trifluoronetil-n-metilbenzilammina
UA94391C2 (ru) Синтез предшественника ингибитора протеазы
EA200802065A1 (ru) Синтез замещённых флуоренов
TW200740366A (en) Novel fluorescent cichlid and method for producing thereof
ATE464280T1 (de) Synthese von idarubin-aglycon

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: JANSSEN SCIENCES IRELAND UC, IE

FC2A Withdrawal, rejection or dismissal of laid open patent application